D-Mannose Market

D-Mannose Market Study by Powder, Capsules, and Tablets for Functional Food, Dietary Supplements, Pharmaceuticals, and Animal Feed from 2024 to 2034

Analysis of D-Mannose Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

D-Mannose Market Outlook (2024 to 2034)

A new Fact.MR research report reveals that the global D-Mannose market is estimated to reach US$ 1.3 billion in 2024. Over the projected period from 2024 to 2034, global demand for D-Mannose has been projected to exhibit 2.9% CAGR, ultimately leading to a market size of US$ 1.72 billion by 2034-end.

Increasing use of D-Mannose as a dietary supplement for the prevention and treatment of UTIs (urinary tract infections) is driving up the profits of market players. Rising awareness about UTIs along with requirements for effective treatment and prevention options is estimated to lead to the increased consumption of D-Mannose. Moreover, the majority of consumers are inclined to use herbal and natural remedies instead of synthetic drugs, which is further projected to positively influence D-Mannose market trends.

Growing incidence of urinary tract infections is expected to contribute to the global market growth. Numerous factors, including improper hygiene practices, lifestyle changes, and antibiotic resistance, are leading to rising cases of UTIs. This is leading to increased adoption of D-Mannose as a preventive measure.

  • East Asia is projected to account for 25.2% share of the global market by 2034.
  • Capsules & tablets are forecasted to contribute 51.08% of the D-Mannose market share by the end of 2034.
  • Demand for D-Mannose in the United States is projected to reach a market value of US$ 267.2 million by the end of 2034.

Increasing health consciousness among more individuals is leading to the adoption of products promoting urinary health. D-Mannose is generally considered beneficial to maintaining urinary tract health, thus attracting health-conscious people to incorporate it into their routine. The aging population is estimated to be more prone to UTIs owing to weakened immune systems and other age-related issues. With the growing demographic of elderly people, an increase in the demand for products, such as D-Mannose is anticipated to rise for urinary health management.

Regulatory approvals and endorsements from respective health authorities are projected to validate the safety and efficacy of D-Mannose, instilling trust among more healthcare professionals and consumers, and therefore driving the market growth.

Report Attributes Details
D-Mannose Market Size (2024E) US$ 1.3 Billion
Forecasted Market Value (2034F) US$ 1.72 Billion
Global Market Growth Rate (2024 to 2034) 2.9% CAGR
South Korea Market Growth (2024 to 2034) 4.1% CAGR
Market Share of Pharmaceuticals (2034F) 25.96%
North America Market Share (2034F) 21.2%
Key Companies Profiled
  • Nestlé Health Science
  • Pfanstiehl Inc.
  • NOW Health Group, Inc.
  • Vibrant Health
  • DuPont de Numerous, Inc.
  • Source Naturals
  • Bio-Tech Pharmacal
  • Nutraceutical International Corporation
  • Swanson Vitamins
  • GNC Holdings, Inc.
  • NutriScience Innovations LLC

Don't Need a Global Report?

save 40%! on Country & Region specific reports

What is Contributing to Rising Consumption of D-Mannose across Regions?

“Rising Demand for Non-GMO Products Benefitting Market Players”

In recent years, a noteworthy inclination toward organic or natural food products has been experienced with rising incidences of discomfort and distrust. Growing concerns about bioengineered food products are projected to increase demand for non-GMO food products, which is stimulating manufacturers of the food & beverage market to adapt to trends. Further, the rising consumption of non-GMO food products is projected to lead to the inclination to D-Mannose to promote normal functioning of the urinary tract by maintaining the health of the bladder.

“Growing Demand for Low-calorie Food Products”

D-Mannose is absorbed comparatively at a slower rate in the human body. Its low glycemic index is further estimated to help in minimizing blood sugar levels. This feature of D-Mannose makes it an effective organic or natural sugar in numerous functional food products. It is not stored in the liver similar to glucose rather it gets filtered out through the kidneys.

Rising consumer preference for low-carbohydrate food products owing to the increasing cases of multiple issues, such as UTIs, cardiovascular, and many others is estimated to lead to increasing inclination to these products. Therefore, manufacturers are concentrating on introducing innovative and new functions in food products with the use of D-mannose.

Which Factors Present Challenges to Market Expansion?

“Side Effects Associated with Prolonged Consumption of D-Mannose”

D-Mannose, used as a therapeutic option for the treatment of urinary tract infections, kidney infections, etc. is estimated to lead to various side effects. These side effects are owing to the prolonged consumption of D-Mannose, which can cause diarrhea, loose stool, bloating, etc.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

How are Startups Expected to Perform in This Market?

“Rising Investments in R&D Activities Aiming to Explore Health Benefits of D-Mannose”

Startups are expected to invest more in R&D activities aimed at exploring the potential health benefits associated with the consumption of D-Mannose. In addition, they are anticipated to work on the efficiency of UTI prevention along with its applications in numerous health conditions. These clinical trials and study outcomes are projected to reinforce consumer confidence, therefore contributing to D-Mannose market growth.

Country-wise Insights

The East Asian region is approximated to hold 25.2% share of global market revenue by the end of 2034, as mentioned in the research report published by Fact.MR. Increasing demand for supplements from health-conscious individuals is projected to lead to increased consumption of D-Mannose in East Asia.

Why is the United States a Key Market for D-Mannose Producers?

“Increasing Use of Natural Ingredients in Food Production”

Attribute United States
Market Value (2024E) US$ 218.2 Million
Growth Rate (2024 to 2034) 2% CAGR
Projected Value (2034F) US$ 267.2 Million

The United States market is anticipated to contribute 73.1% of the total revenue generated in North America by 2034. Numerous manufacturers from the food & beverage industry are giving preference to natural ingredients for the production of nutritional and organic food products, which is further contributing to the expansion of the D-Mannose market size.

What Makes China a Prominent Market in the East Asian Region?

“Rising Use of Supplements by Health-Conscious Consumers”

Attribute China
Market Value (2024E) US$ 221.6 Million
Growth Rate (2024 to 2034) 3.2% CAGR
Projected Value (2034F) US$ 304.2 Million

China is set to enjoy a share of 70% in the East Asian regional market by the end of 2034. Growth in the country is attributed to the growing use of supplements by health-conscious people. In addition, increased awareness about the risks associated with bladder health and UTIs is projected to generate demand for numerous health supplements. More people in China are increasing their expenditure on preventive health, which has widened the scope for D-Mannose suppliers.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Category-wise Insights

Fact.MR, a market research and competitive intelligence provider, in its study, asserts that online retail sales channel is estimated to be in increased use for the sales of D-mannose. Hustle-free purchase of various products, rising consumer preference for online distribution channels, and rapid penetration of online channels are anticipated to contribute to increased inclination to these e-Commerce platforms.

Why Do Most Consumers prefer D-Mannose Capsules & Tablets?

“Rising Consumption of D-Mannose Capsules & Tablets for Convenience and Standardized Dosage”

Attribute Capsules & Tablets
Segment Value (2024E) US$ 673 Million
Growth Rate (2024 to 2034) 2.7% CAGR
Projected Value (2034F) US$ 881 Million

Capsules & tablets account for 51.74% share of the global market in 2024. This form of D-Mannose offers an easy and convenient way for consumption. These capsules & tablets are taken with water or other liquids, therefore making them more suitable for individuals preferring a simple dosing method or having busy lifestyles. Further, capsules & tablet forms of D-Mannose allow for precise dosage control with the presence of standardized per unit dose. It ensures easy determination of the appropriate dose to achieve desired health benefits.

Which End Use of D-Mannose is More Rewarding for Suppliers?

“Growing Preference for Natural Remedies than Conventional Ones in Pharmaceuticals”

Attribute Pharmaceuticals
Segment Value (2024E) US$ 345 Million
Growth Rate (2024 to 2034) 2.6% CAGR
Projected Value (2034F) US$ 448 Million

Pharmaceuticals are projected to be one of the prominent end users of D-mannose and are approximated to hold 25.96% share of global market revenue by 2034. The majority of individuals and healthcare providers are giving preference to natural remedies rather than traditional ones owing to the rising concerns related to their side effects and antibiotic resistance.

D-Mannose is becoming popular as a natural sugar, which is generally found in fruits, such as cranberries. In addition, growing traction for D-Mannose as a natural alternative for the prevention and treatment of UTIs is also driving opportunities for suppliers.

Competitive Landscape

Companies are engaged in the production of D-mannose and are investing in related innovation, expansion, and R&D activities. They use contemporary manufacturing technology to get a competitive edge. New development, offering quality products, managing supply chain systems, etc. are some other initiatives, which are expected to help players drive sales in the market.

Key players in the D-mannose market are Nestlé Health Science, Pfanstiehl Inc., NOW Health Group, Inc., Vibrant Health, DuPont de Numerous, Inc., Source Naturals, Bio-Tech Pharmacal, Nutraceutical International Corporation, Swanson Vitamins, GNC Holdings, Inc., NutriScience Innovations LLC.

Segmentation of D-mannose Market Research

  • By Form :

    • Powder
    • Capsules & Tablets
  • By End Use :

    • Functional Food
    • Dietary Supplements
    • Pharmaceuticals
    • Animal Feed
    • Others
  • By Sales Channel :

    • Business to Business
    • Business to Consumer
      • Hypermarkets/Supermarkets
      • Convenience Stores
      • Specialty Stores
      • Online Retail
  • By Region :

    • North America
    • Europe
    • East Asia
    • Latin America
    • Middle East & Africa
    • South Asia & Oceania

- FAQs -

How big is the size of the D-Mannose market in 2024?

The global D-mannose market is poised to reach US$ 1.3 billion in 2024.

What is the forecasted value of the global market for 2034?

Worldwide sales of D-mannose are projected to reach US$ 1.72 billion by 2034-end.

What are the demand projections for D-Mannose from 2024 to 2034?

The market for D-mannose is projected to advance at a CAGR of 2.9% from 2024 to 2034.

What is the anticipated contribution of East Asia to global market revenue?

East Asia is projected to hold 25.2% share of the global market by 2034.

What is the sales forecast for D-Mannose in South Korea?

Demand for D-mannose in South Korea is approximated to increase at a CAGR of 4.1% from 2024 to 2034.

Which form of D-Mannose is expected to account for a higher market share?

D-mannose Capsules & tablets are forecasted to account for 51.08% share of global market revenue by 2034.

D-Mannose Market

Schedule a Call